No connection

Search Results

MMSI vs RDNT

MMSI
Merit Medical Systems, Inc.
NEUTRAL
Price
$70.54
Market Cap
$4.21B
Sector
Healthcare
AI Confidence
80%
RDNT
RadNet, Inc.
BEARISH
Price
$60.39
Market Cap
$4.69B
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
MMSI
33.12
RDNT
--
Forward P/E
MMSI
16.04
RDNT
58.82
P/B Ratio
MMSI
2.65
RDNT
4.29
P/S Ratio
MMSI
2.77
RDNT
2.3
EV/EBITDA
MMSI
14.4
RDNT
24.88

Profitability

Gross Margin
MMSI
48.7%
RDNT
18.17%
Operating Margin
MMSI
15.78%
RDNT
6.83%
Profit Margin
MMSI
8.48%
RDNT
-0.91%
ROE
MMSI
8.67%
RDNT
1.37%
ROA
MMSI
4.75%
RDNT
1.61%

Growth

Revenue Growth
MMSI
10.9%
RDNT
14.8%
Earnings Growth
MMSI
38.8%
RDNT
--

Financial Health

Debt/Equity
MMSI
0.52
RDNT
1.37
Current Ratio
MMSI
4.34
RDNT
1.76
Quick Ratio
MMSI
2.79
RDNT
1.67

Dividends

Dividend Yield
MMSI
--
RDNT
--
Payout Ratio
MMSI
0.0%
RDNT
0.0%

AI Verdict

MMSI NEUTRAL

MMSI presents a dichotomy between strong fundamental growth and poor market sentiment. While the Piotroski F-Score of 4/9 indicates stable but not strong financial health, the company boasts an exceptional track record of earnings beats over 25 quarters and strong YoY earnings growth of 38.8%. However, the stock is currently trading at $70.54, which is a premium to its Intrinsic Value ($62.83) and significantly above its Graham Number ($35.75). Bearish insider activity and a 0/100 technical trend offset the bullish analyst target of $101.18.

Strengths
Exceptional earnings track record with consistent beats over 25 quarters
Strong liquidity position with a Current Ratio of 4.34
Significant earnings growth (38.8% YoY) and positive Q/Q momentum
Risks
Trading at a premium to both Graham Number and Intrinsic Value
Strongly bearish insider sentiment with $5.64M in recent sales
Severe negative technical trend (0/100) and 1Y price decline of 24.4%
RDNT BEARISH

RDNT exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health and deteriorating operational efficiency. While revenue growth remains positive at 14.8%, the company is struggling with negative profit margins (-0.91%) and a catastrophic collapse in year-over-year EPS growth (-104.5%). There is a stark divergence between the 'Strong Buy' analyst consensus and the bearish reality of insider selling and negative earnings surprises. The valuation is aggressive, with a forward P/E of 58.82 that is not supported by current profitability.

Strengths
Consistent double-digit revenue growth (14.8% YoY)
Healthy short-term liquidity with a Current Ratio of 1.76
Strong long-term price appreciation (171.5% over 5 years)
Risks
Critical financial health failure (Piotroski F-Score 2/9)
Severe earnings deterioration (-104.5% YoY EPS growth)
Negative net profit margins indicating inability to convert revenue to bottom-line profit

Compare Another Pair

MMSI vs RDNT: Head-to-Head Comparison

This page compares Merit Medical Systems, Inc. (MMSI) and RadNet, Inc. (RDNT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile